The Limited Times

Now you can see non-English news...

CUHK Research: The antibody level of Kexing vaccine vaccinators has dropped sharply for several months, and now a third injection is given

2021-08-18T03:39:50.948Z


The antibody level of people who injected the Kexing vaccine is often or insufficient. A study by Xu Shuchang, Chair Professor of Respiratory System at the Chinese University of China, found that the antibody level of the vaccinator had fallen to a low level within a few months, which surprised him. Today (18


The antibody level of people who have injected the Kexing vaccine is often or insufficient. A study by Xu Shuchang, Chair Professor of Department of Respiratory System at Chinese University, found that the antibody level of the vaccinator had fallen to a low level within a few months, which surprised him. Today (18th) will be Some people received the third injection, half received the Kexing vaccine, and the other half received the Fubitai vaccine.


Citizens are vaccinated with Kexing vaccine.

(Profile picture)

Xu Shuchang said on the commercial radio program that 700 people were recruited at the vaccination center on April 1 this year. Among them, 350 were vaccinated with Kexing vaccine and 350 were vaccinated with Fubital vaccine. He was surprised that 80 of the 160 KX vaccinators had a low level of antibodies for the new coronavirus. He was surprised that they would be given a third shot. Today, there will be more than 20 people. Going to the Zhongda Hospital for an injection, next week, there will be more than 20 people who are given the Kexing vaccine, half of them, 40 people, and the other half, 40 people being given the Fubitai vaccine.

He quoted Kexing Pharmaceuticals as saying that the third dose of Kexing vaccine can increase the antibody level by seven times, and there are mixed-injection studies overseas, hoping to provide the government with answers to the antibody level of mixed-injection.

However, he said that in addition to antibodies that can protect the vaccinated, the vaccine will also stimulate T cell protection in the body. The protection of Kexing and Fubitai vaccines are similar and can avoid the risk of severe illness and death after infection. Antibodies are used to prevent the onset of disease after infection. .

▼From July 8th, measures to maintain social distancing generally under the framework of the "vaccine bubble"▼


+15

Medical experts have recently urged the public to abandon the idea of ​​immune barrier. Xu Shuchang said that "it is not the same way of expression, and everyone must always build an immune barrier." Quoting Singapore and the United Kingdom experience, as long as the vaccination rate reaches 70 to 80%, the vaccination rate of high-risk groups is high. Even if there is an outbreak of an epidemic, the medical system will not collapse, but the vaccination rate in Hong Kong is still only 55%, and there is no condition to substantially relax the epidemic prevention regulations.

Zeng Qiyin, the co-chairman of the Infectious Disease Advisory Committee of the Medical Association, said on the Radio Hong Kong program that he should be careful to interpret the saying "abandon the immune barrier." Don’t wear a mask, you can still get infected and spread”, which also implies that even if the vaccination rate is high, the epidemic prevention regulations may not be loosened in a short time.

▼On July 29, the community vaccination center will distribute same-day injections to the elderly▼


+1

01 Exclusive|Private doctor used contraceptive injections to wrongly give Kexing a new crown vaccine. Fubitai was vaccinated and the victim was "groove-injected" the new crown vaccine. |The 3 elderly health centers of the Department of Health will vaccinate the elderly without making an appointment for the new crown vaccine.|The University of Hong Kong Research: The level of antibodies produced by Kexing is not as good as that of Fubitel.

01News

Source: hk1

All news articles on 2021-08-18

You may like

Trends 24h

News/Politics 2024-03-27T16:45:54.081Z

Latest

© Communities 2019 - Privacy

The information on this site is from external sources that are not under our control.
The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.